Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.

MLA

Wani, Manzoor A., et al. “Entecavir Is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.” Journal of Clinical and Experimental Hepatology, vol. 10, no. 2, Mar. 2020, pp. 150–54. EBSCOhost, https://doi.org/10.1016/j.jceh.2019.04.002.

APA

Wani, M. A., Sodhi, J. S., Zargar, S. A., Yatoo, G. N., Shah, A., Aziz, S. A., Geelani, S., Haq, I., Gulzar, G. M., Khan, M., & Haq, I. (2020). Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children. Journal of Clinical and Experimental Hepatology, 10(2), 150–154. https://doi.org/10.1016/j.jceh.2019.04.002

Chicago

Wani, Manzoor A, Jaswinder S Sodhi, Showkat A Zargar, Ghulam N Yatoo, Altaf Shah, Sheikh A Aziz, Sajad Geelani, et al. 2020. “Entecavir Is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.” Journal of Clinical and Experimental Hepatology 10 (2): 150–54. doi:10.1016/j.jceh.2019.04.002.